COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL studyThomas Chatzikonstantinou, Elżbieta Kalicińska, Anargyros Kapetanakis et al.|Leukemia|2021Cited by 94
The evolving landscape of <scp>COVID</scp>‐19 and <scp>post‐COVID</scp> condition in patients with chronic lymphocytic leukemia: A study by <scp>ERIC</scp>, the <scp>European</scp> research initiative on <scp>CLL</scp>Andrea Visentin, Gilad Itchaki, Thomas Chatzikonstantinou et al.|American Journal of Hematology|2023Cited by 21
Second primary malignancies in treated and untreated patients with chronic lymphocytic leukemiaMoritz Fürstenau, Anna‐Maria Fink, Ali Aldaoud et al.|American Journal of Hematology|2021Cited by 9
Differences in Clinical Course and Management of Sars-CoV2 Infection in Patients with Chronic Lymphocytic Leukemia between the Sequential Pandemic Phases: An Eric StudyAndrea Visentin, Mark‐David Levin, Lydia Scarfò et al.|Blood|2022Cited by 0